Rising Conservative Voice Vince Coglianese Joins National Conversation with New Live Radio Show and Podcast
The VINCE ShowVINCE
NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- Cumulus Media (NASDAQ: CMLS) announces The VINCE Show and VINCE podcast will launch on March 17. Westwood One will syndicate the all-new live radio broadcast hosted by Vince Coglianese, popular Washington, DC-based radio host on WMAL-FM, Editorial Director of the conservative daily news publication, The Daily Caller, and frequent guest host of The Dan Bongino Show. Silverloch Productions, founded by Dan and Paula Bongino, will produce the VINCE podcast to be distributed by the Cumulus Podcast Network. The new radio show will air weekdays from 12 to 3 p.m. ET with the 1-hour podcast dropping prior on weekday mornings.
The VINCE Show and VINCE podcast are set to redefine conservative talk with their compelling mix of Vince's signature blend of insight into and knowledge of the inner workings of Washington, DC, in-depth interviews, and live caller interactions. Vince's authenticity and relatability ensure that every discussion is both engaging and thought-provoking, creating a vibrant community of informed listeners who have a front-row seat to the most important conversations of the day.
The VINCE Show will launch on Westwood One with over 250 affiliates, including top market stations KABC-AM (Los Angeles), WLS-AM (Chicago), WBAP-AM (Dallas), KSFO-AM (San Francisco), WMAL-FM (Washington, DC), and KCMO-AM/FM (Kansas City). Cumulus Podcast Network will handle the distribution, sales, and marketing for the VINCE podcast, as part of Silverloch's wider portfolio of podcasts.
With nearly two decades of experience in conservative journalism and broadcasting, Vince has become a trusted voice in the industry. His tenure at WMAL's Mornings on the Mall saw the show reach number one in the DC market and his current show, The Vince Coglianese Show, continues to captivate audiences with its refreshing take on the day's biggest stories. Additionally, Vince frequently fills in as guest host on The Dan Bongino Show and makes regular appearances on some of today's most popular conservative television news shows. His ability to connect with listeners and guests alike has earned Vince a spot among Talkers Magazine's 'Heavy Hundred: list of the most important radio talk show hosts in America.'
"I am beyond thrilled to be stepping into this role with Westwood One and Silverloch and can't thank my WMAL family in Washington enough for the 8 incredible years we've already spent together. I also want to offer a special thank you to Dan Bongino for selflessly returning to service for his country. His decency and sacrifice are a true testament to his character,' said Coglianese. Adding, "Now we take things to the next level. I'm deeply conscious of the history-making legacies of these broadcasts, which is why we will be delivering the ultimate 3-hour live radio show and 1-hour podcast for the millions of Americans who demand the truth. I promise this will be the most entertaining, informative, and efficient way to equip yourself in the golden age of America. I can't wait for March 17th, and I hope you'll join me."
'Vince's star has been on the rise, and we're thrilled to welcome him to the unparalleled Westwood One platform to expand his reach even further,' said Collin Jones, President of Westwood One and EVP, Corporate Strategy and Development for Cumulus Media. 'Vince's unparalleled ability to combine realism with sharp political insight makes him the ideal host to captivate audiences across both live radio and podcasting. The VINCE Show and VINCE podcast will quickly become cornerstones of our industry-leading conservative talk lineup.'
'Vince brings a fresh and engaging perspective to conservative talk radio, and I am thrilled to see him join our portfolio and the Westwood One lineup,' said Paula Bongino. 'As my husband Dan embarks on his new role as Deputy Director of the FBI, we are both confident Vince's ability to connect with listeners and tackle important issues with both passion and clarity will guide the future of conservative media.'
Westwood One has a storied history in broadcasting, known for its commitment to delivering high-quality conservative talk radio. The addition of The VINCE Show continues this legacy, promising to bring fresh perspectives and lively discussions to listeners across the nation.
For information on affiliating The VINCE Show radio program, please contact Stuart Greenblatt (sgreenblatt@westwoodone.com). The VINCE podcast will be available on CumulusPodcastNetwork.com, all major podcast platforms, and on Rumble.
About Cumulus Media Cumulus Media (NASDAQ: CMLS) is an audio-first media company delivering premium content to a quarter billion people every month — wherever and whenever they want it. Cumulus Media engages listeners with high-quality local programming through 400 owned-and-operated radio stations across 84 markets; delivers nationally-syndicated sports, news, talk, and entertainment programming from iconic brands including the NFL, the NCAA, the Masters, Infinity Sports Network, AP News, the Academy of Country Music Awards, and many other world-class partners across more than 9,500 affiliated stations through Westwood One, the largest audio network in America; and inspires listeners through the Cumulus Podcast Network, its rapidly growing network of original podcasts that are smart, entertaining and thought-provoking. Cumulus Media provides advertisers with personal connections, local impact and national reach through broadcast and on-demand digital, mobile, social, and voice-activated platforms, as well as integrated digital marketing services, powerful influencers, full-service audio solutions, industry leading research and insights, and live event experiences. For more information visit www.cumulusmedia.com.
About Silverloch ProductionsSilverloch is more than a media company. It is a movement. Built on truth, conviction and a commitment to shaping culture, Silverloch is dedicated to amplifying voices that matter. We believe in bold storytelling, fearless journalism, and content that challenges the status quo. With a foundation rooted in faith, freedom, and the principles that build this nation, Silverloch is creating a new standard in media where integrity leads, and influence follows. From groundbreaking investigative reports to dynamic shows and digital-first content, Silverloch is where the future of media takes shape.
Contact:
Lisa Dollinger | Cumulus Media | lisacdollinger@gmail.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indianapolis Star
31 minutes ago
- Indianapolis Star
New to The Street Episode #671 Airs Tonight on Bloomberg Television at 6:30 PM EST Featuring FLOKI, Arrive AI (NASDAQ: ARAI), Health In Tech (NASDAQ: HIT), Vita Bella, and NRX Pharmaceuticals (NASDAQ: NRXP)
This week's episode is sponsored by The Sustainable Green Team's Waterless Garden (OTC:SGTM) and PetVivo Holdings, Inc.'s (NASDAQ:PETV) innovative SPRYNG™ product. NEW YORK CITY, NY / ACCESS Newswire / June 14, 2025 / New to The Street, the nationally syndicated business television series known for spotlighting innovation across sectors, announces the premiere of Episode #671 airing tonight on Bloomberg Television at 6:30 PM EST. This week's broadcast features five dynamic companies making waves across blockchain, AI, health tech, wellness, and pharmaceutical sectors: FLOKI – The globally recognized crypto and blockchain brand building Web3 utility through its DeFi ecosystem. Arrive AI (NASDAQ:ARAI) – Developer of a patented smart mailbox delivery platform, leading last-mile logistics innovation with its autonomous, AI-powered systems. Health In Tech (NASDAQ:HIT) – A pioneer in digital underwriting and quote-to-card technology for health insurance, transforming how plans are built and priced. Vita Bella – A wellness brand that continues to expand its national presence through health-focused lifestyle offerings. NRX Pharmaceuticals (NASDAQ:NRXP) – A late-stage pharmaceutical company advancing treatments for CNS disorders and respiratory distress. This week's featured corporate sponsors include: The Sustainable Green Team (OTC:SGTM) and its revolutionary Waterless Garden initiative for drought-resistant, sustainable landscaping. PetVivo Holdings, Inc. (NASDAQ:PETV), showcasing continued progress with its SPRYNG™, a veterinary injectable device for treating osteoarthritis in companion animals. Upcoming Highlights: New to The Street has also wrapped filming this week with several prominent brands: GLINT Pay (Private) – A disruptive gold-as-money platform allowing real-time gold transactions. Lahontan Gold Corp. (TSX.V:LG / OTCQB:LGCXF) – Canadian gold exploration company with high-grade assets in Nevada. Greer Consulting Group – Providing strategic solutions across regulatory compliance, M&A, and executive strategy. Special Feature Segment: A culinary showcase from two of New York City's most iconic dining destinations – Black Barn and Hunt & Fish Club – blending luxury hospitality with the business of restaurant branding. Additionally, special segments fromIMG Academy, Skip Barber Racing School, and KITON will continue to roll out in the coming months as part of New to The Street's ongoing coverage of elite performance, luxury, and innovation. Quote from Vince Caruso, Creator and Executive Producer of New to The Street: 'We continue to be a destination for innovative and publicly traded companies ready to tell their story at scale. Tonight's show blends AI, healthcare, crypto, and wellness with real national TV exposure. We're proud to feature these brands and grateful to our show sponsors for helping amplify their messages.' About New to The Street Since 2009, New to The Street has become one of the most trusted platforms for public and private companies to share their stories. The show combines sponsored programming with earned media, enhanced by iconic outdoor campaigns, nationwide TV commercials, and non-deal roadshows that connect executives with top-tier investors and institutions. With weekly reach across 220 million linear TV households, a growing 2.65 million YouTube subscribers, and a robust social media presence exceeding 700,000 followers across LinkedIn, Facebook, Instagram, and X, New to The Street delivers unparalleled exposure and credibility in the business media space. For more information, visit SOURCE: New To The Street View the original press release on ACCESS Newswire
Yahoo
32 minutes ago
- Yahoo
OKYO Pharma Limited's (NASDAQ:OKYO) market cap up US$38m last week, benefiting both individual investors who own 58% as well as insiders
OKYO Pharma's significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public 42% of the business is held by the top 12 shareholders Insider ownership in OKYO Pharma is 36% We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. A look at the shareholders of OKYO Pharma Limited (NASDAQ:OKYO) can tell us which group is most powerful. We can see that individual investors own the lion's share in the company with 58% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn). Following a 58% increase in the stock price last week, individual investors profited the most, but insiders who own 36% stock also stood to gain from the increase. Let's take a closer look to see what the different types of shareholders can tell us about OKYO Pharma. View our latest analysis for OKYO Pharma Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index. As you can see, institutional investors have a fair amount of stake in OKYO Pharma. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of OKYO Pharma, (below). Of course, keep in mind that there are other factors to consider, too. We note that hedge funds don't have a meaningful investment in OKYO Pharma. Gabriele Marco Cerrone is currently the largest shareholder, with 29% of shares outstanding. For context, the second largest shareholder holds about 6.8% of the shares outstanding, followed by an ownership of 5.9% by the third-largest shareholder. Our studies suggest that the top 12 shareholders collectively control less than half of the company's shares, meaning that the company's shares are widely disseminated and there is no dominant shareholder. Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There is a little analyst coverage of the stock, but not much. So there is room for it to gain more coverage. While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it. Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group. Our information suggests that insiders maintain a significant holding in OKYO Pharma Limited. Insiders have a US$37m stake in this US$102m business. It is great to see insiders so invested in the business. It might be worth checking if those insiders have been buying recently. The general public, who are usually individual investors, hold a substantial 58% stake in OKYO Pharma, suggesting it is a fairly popular stock. This level of ownership gives investors from the wider public some power to sway key policy decisions such as board composition, executive compensation, and the dividend payout ratio. I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. To that end, you should learn about the 4 warning signs we've spotted with OKYO Pharma (including 2 which make us uncomfortable) . If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
44 minutes ago
- Yahoo
ExlService Holdings (NASDAQ:EXLS) Is Very Good At Capital Allocation
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in conjunction with a growing amount of capital employed. Basically this means that a company has profitable initiatives that it can continue to reinvest in, which is a trait of a compounding machine. Speaking of which, we noticed some great changes in ExlService Holdings' (NASDAQ:EXLS) returns on capital, so let's have a look. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. To calculate this metric for ExlService Holdings, this is the formula: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.20 = US$281m ÷ (US$1.7b - US$244m) (Based on the trailing twelve months to March 2025). Thus, ExlService Holdings has an ROCE of 20%. That's a fantastic return and not only that, it outpaces the average of 14% earned by companies in a similar industry. View our latest analysis for ExlService Holdings Above you can see how the current ROCE for ExlService Holdings compares to its prior returns on capital, but there's only so much you can tell from the past. If you'd like, you can check out the forecasts from the analysts covering ExlService Holdings for free. The trends we've noticed at ExlService Holdings are quite reassuring. The numbers show that in the last five years, the returns generated on capital employed have grown considerably to 20%. Basically the business is earning more per dollar of capital invested and in addition to that, 42% more capital is being employed now too. So we're very much inspired by what we're seeing at ExlService Holdings thanks to its ability to profitably reinvest capital. A company that is growing its returns on capital and can consistently reinvest in itself is a highly sought after trait, and that's what ExlService Holdings has. And with the stock having performed exceptionally well over the last five years, these patterns are being accounted for by investors. Therefore, we think it would be worth your time to check if these trends are going to continue. ExlService Holdings does have some risks though, and we've spotted 1 warning sign for ExlService Holdings that you might be interested in. If you want to search for more stocks that have been earning high returns, check out this free list of stocks with solid balance sheets that are also earning high returns on equity. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
